Pages that link to "Q44755691"
Jump to navigation
Jump to search
The following pages link to Obesity and diabetes as a risk factor for hepatocellular carcinoma (Q44755691):
Displaying 50 items.
- Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma (Q24635267) (← links)
- Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances (Q26745338) (← links)
- Risk factors for hepatocellular carcinoma in India (Q26830794) (← links)
- Biological networks for predicting chemical hepatocarcinogenicity using gene expression data from treated mice and relevance across human and rat species (Q28533447) (← links)
- Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine (Q30301218) (← links)
- Non-viral causes of hepatocellular carcinoma (Q34041381) (← links)
- Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells (Q34078634) (← links)
- Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis (Q34084962) (← links)
- Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. (Q34255487) (← links)
- Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma (Q34258684) (← links)
- Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review (Q34304174) (← links)
- Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis (Q34560811) (← links)
- Epidemiology of Primary and Secondary Liver Cancers (Q34563350) (← links)
- Liver resection in obese patients: results of a case-control study. (Q34602259) (← links)
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (Q34617479) (← links)
- Non-viral factors contributing to hepatocellular carcinoma (Q34653639) (← links)
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging (Q34966603) (← links)
- Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population (Q35096951) (← links)
- Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice (Q35679343) (← links)
- Hepatitis C virus infection: establishment of chronicity and liver disease progression (Q35728873) (← links)
- Potential role of leptin expression in hepatocellular carcinoma (Q35770282) (← links)
- Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation (Q36165357) (← links)
- Hepatocellular carcinoma: natural history, current management, and emerging tools (Q36171275) (← links)
- Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience (Q36231233) (← links)
- Is liver disease a threat to patients with metabolic disorders? (Q36265230) (← links)
- Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence (Q36518996) (← links)
- Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma (Q36581465) (← links)
- Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis (Q36815013) (← links)
- The role of chronic inflammation in obesity-associated cancers (Q36931512) (← links)
- Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers. (Q37116105) (← links)
- Molecular mechanisms of hepatocellular carcinoma (Q37323726) (← links)
- Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma (Q37417134) (← links)
- Obesity, inflammation, and liver cancer (Q37469981) (← links)
- Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats (Q37503151) (← links)
- Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma (Q37588455) (← links)
- Emerging Raf inhibitors. (Q37588717) (← links)
- Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. (Q37622144) (← links)
- Several microRNAs could predict survival in patients with hepatitis B-related liver cancer (Q37713066) (← links)
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection (Q37739949) (← links)
- Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? (Q37932057) (← links)
- Iron overload in nonalcoholic steatohepatitis (Q37962556) (← links)
- Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis (Q38040323) (← links)
- Management and diagnosis of fatty liver disease (Q38365276) (← links)
- Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review (Q38397273) (← links)
- Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma (Q39042825) (← links)
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. (Q39902214) (← links)
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis (Q40332880) (← links)
- Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome (Q40707598) (← links)
- Laparoscopic liver resection in obese patients. (Q41621887) (← links)
- Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report (Q42322703) (← links)